You are here

Article info

Article menu

Download PDFPDF

Paediatric rheumatology
Clinical case
Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children

Authors

  • Natalia Cabrera Department of Pediatric Rheumatology, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Agnes Duquesne PubMed articlesGoogle scholar articles
  • Marine Desjonquères Department of Pediatric Rheumatology, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Jean-Paul Larbre Department of Rheumatology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Pierre-Bénite, France PubMed articlesGoogle scholar articles
  • Jean-Christophe Lega Department of Internal and Vascular Medicine, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Lyon, France Laboratoire de Biométrie et Biologie Evolutive, CNRS, Claude Bernard University Lyon 1, University of Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Nicole Fabien Department of Immunology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France PubMed articlesGoogle scholar articles
  • Alexandre Belot Department of Pediatric Rheumatology, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Claude Bernard University Lyon 1, University of Lyon, Lyon, France INSERM U1111 PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Alexandre Belot; alexandre.belot{at}chu-lyon.fr
View Full Text

Citation

Cabrera N, Duquesne A, Desjonquères M, et al
Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children
RMD Open 2016;2:e000271. doi: 10.1136/rmdopen-2016-000271

Publication history

  • Received February 26, 2016
  • Revision received June 28, 2016
  • Accepted July 11, 2016
  • First published September 15, 2016.
Online issue publication 
July 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/